Bailard, Inc. Neurocrine Biosciences Inc Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $341,523 - $465,660	-3,900 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$86.8 - $118.57 $86,800 - $118,570	-1,000 Reduced 20.41%	3,900 $419,000
Q1 2018 May 07, 2018	SELL	$75.88 - $92.43 $151,760 - $184,860	-2,000 Reduced 28.99%	4,900 $406,000
Q4 2017 Feb 08, 2018	BUY	$58.53 - $77.59 $403,857 - $535,371	6,900	6,900 $0

642

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.